Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation

医学 心源性休克 体外膜肺氧合 体温过低 麻醉 休克(循环) 随机对照试验 心脏病学 内科学 心肌梗塞
作者
Bruno Lévy,Nicolas Girerd,Julien Amour,Emmanuel Besnier,Nicolas Nesseler,Julie Helms,Clément Delmas,Romain Sonneville,C. Guidon,Bertrand Rozec,Hélène David,David Bougon,Oussama Chaouch,Walid Oulehri,Dupont Hervé,Nicolas Belin,Lucie Gaide‐Chevronnay,Patrick Rossignol,Antoine Kimmoun,Kévin Duarte
出处
期刊:JAMA [American Medical Association]
卷期号:327 (5): 442-442 被引量:79
标识
DOI:10.1001/jama.2021.24776
摘要

Importance The optimal approach to the use of venoarterial extracorporeal membrane oxygenation (ECMO) during cardiogenic shock is uncertain. Objective To determine whether early use of moderate hypothermia (33-34 °C) compared with strict normothermia (36-37 °C) improves mortality in patients with cardiogenic shock receiving venoarterial ECMO. Design, Setting, and Participants Randomized clinical trial of patients (who were eligible if they had been endotracheally intubated and were receiving venoarterial ECMO for cardiogenic shock for <6 hours) conducted in the intensive care units at 20 French cardiac shock care centers between October 2016 and July 2019. Of 786 eligible patients, 374 were randomized. Final follow-up occurred in November 2019. Interventions Early moderate hypothermia (33-34 °C; n = 168) for 24 hours or strict normothermia (36-37 °C; n = 166). Main Outcomes and Measures The primary outcome was mortality at 30 days. There were 31 secondary outcomes including mortality at days 7, 60, and 180; a composite outcome of death, heart transplant, escalation to left ventricular assist device implantation, or stroke at days 30, 60, and 180; and days without requiring a ventilator or kidney replacement therapy at days 30, 60, and 180. Adverse events included rates of severe bleeding, sepsis, and number of units of packed red blood cells transfused during venoarterial ECMO. Results Among the 374 patients who were randomized, 334 completed the trial (mean age, 58 [SD, 12] years; 24% women) and were included in the primary analysis. At 30 days, 71 patients (42%) in the moderate hypothermia group had died vs 84 patients (51%) in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.45 to 1.13], P = .15; risk difference, −8.3% [95% CI, −16.3% to −0.3%]). For the composite outcome of death, heart transplant, escalation to left ventricular assist device implantation, or stroke at day 30, the adjusted odds ratio was 0.57 (95% CI, 0.36 to 0.90; P = .02) for the moderate hypothermia group compared with the normothermia group and the risk difference was −12.7% (95% CI, −22.3% to −3.2%). Of the 31 secondary outcomes, 30 were inconclusive. The incidence of moderate or severe bleeding was 41% in the moderate hypothermia group vs 42% in the normothermia group. The incidence of infections was 52% in both groups. The incidence of bacteremia was 20% in the moderate hypothermia group vs 30% in the normothermia group. Conclusions and Relevance In this randomized clinical trial involving patients with refractory cardiogenic shock treated with venoarterial ECMO, early application of moderate hypothermia for 24 hours did not significantly increase survival compared with normothermia. However, because the 95% CI was wide and included a potentially important effect size, these findings should be considered inconclusive. Trial Registration ClinicalTrials.gov Identifier: NCT02754193
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
拔丝奶豆腐完成签到,获得积分10
2秒前
念兹在兹发布了新的文献求助10
2秒前
张伟发布了新的文献求助10
2秒前
仰望苍穹发布了新的文献求助30
3秒前
111发布了新的文献求助10
3秒前
3秒前
3秒前
lfc发布了新的文献求助10
3秒前
YANGYINGSHUO发布了新的文献求助10
4秒前
4秒前
4秒前
ivy18完成签到,获得积分10
4秒前
科研通AI65的应助被允蓥采纳,获得10
5秒前
5秒前
5秒前
5秒前
5秒前
5秒前
DaoXiaolang完成签到,获得积分10
6秒前
6秒前
6秒前
章鱼完成签到,获得积分10
6秒前
英吉利25发布了新的文献求助10
6秒前
6秒前
Wait完成签到,获得积分10
6秒前
Xiao完成签到,获得积分10
6秒前
aaa完成签到,获得积分10
7秒前
7秒前
曾经铅笔发布了新的文献求助10
7秒前
孙家贝发布了新的文献求助10
7秒前
7秒前
7秒前
张泽鑫发布了新的文献求助50
8秒前
ZT1发布了新的文献求助10
8秒前
Yoeyvol完成签到,获得积分10
8秒前
Mxy发布了新的文献求助10
8秒前
充电宝的应助被星河采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572482
关于积分的说明 21825940
捐赠科研通 7780074
什么是DOI,文献DOI怎么找? 3433945
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480166